551
Participants
Start Date
September 30, 2007
Primary Completion Date
March 31, 2009
Study Completion Date
March 31, 2009
Azilsartan medoxomil and chlorthalidone
Azilsartan medoxomil 40 mg, tablets, orally, once daily; azilsartan medoxomil 80 mg placebo-matching tablets, orally, once daily; and chlorthalidone 25 mg, tablets, orally, once daily for up to 6 weeks.
Azilsartan medoxomil and chlorthalidone
Azilsartan medoxomil 80 mg, tablets, orally, once daily; azilsartan medoxomil 40 mg placebo-matching tablets, orally, once daily and chlorthalidone 25 mg, tablets, orally, once daily for up to 6 weeks.
Chlorthalidone
Chlorthalidone 25 mg, tablets, orally, once daily; azilsartan medoxomil 80 mg placebo-matching tablets, orally, once daily and azilsartan medoxomil 40 mg placebo-matching tablets, orally, once daily for up to 6 weeks.
Huntsville
Montgomery
Buena Park
Huntington Beach
Long Beach
Mission Viejo
Roseville
Sacramento
Westlake Village
Coral Gables
DeLand
Fort Lauderdale
Hollywood
Miami
Auburn
Bingham Farms
Troy
Charlotte
Huntersville
Shelby
Akron
Centerville
Cincinnati
Willoughby Hills
Zanesville
Norman
Oklahoma City
Eugene
Portland
Tualatin
Bensalem
Feasterville
Cranston
Simpsonville
Kingsport
Corpus Christi
Houston
Pearland
San Antonio
Salt Lake City
Arlington
Burke
Richmond
Lakewood
Olympia
Port Orchard
Lead Sponsor
Takeda
INDUSTRY